What is the optimal therapy for patients with H5N1 influenza?
In a 2007 article in PLoS Medicine[10], Holger J. Schünemann and colleagues described a new process used by the World Health Organization for rapidly developing clinical management guidelines in emergency situations. These situations include outbreaks of emerging infectious diseases. The authors dis...
Main Authors: | Nicholas J White, Robert G Webster, Elena A Govorkova, Timothy M Uyeki |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-06-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC2694988?pdf=render |
Similar Items
-
H5N1 Outbreaks and Enzootic Influenza
by: Robert G. Webster, et al.
Published: (2006-01-01) -
Family Clustering of Avian Influenza A (H5N1)
by: Sonja J. Olsen, et al.
Published: (2005-11-01) -
Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.
by: Natalia A Ilyushina, et al.
Published: (2008-04-01) -
Detecting Human-to-Human Transmission of Avian Influenza A (H5N1)
by: Ira M. Longini, et al.
Published: (2007-12-01) -
Incubation Period for Human Cases of Avian Influenza A (H5N1) Infection, China
by: Yang Huai, et al.
Published: (2008-11-01)